[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
@BiotechAnalysst Phoenix Biotech XXXPhoenix Biotech XXX posts on X about $sgmo, $4503t, $bmrn, $xbi the most. They currently have XXXXX followers and 1585 posts still getting attention that total XXXXX engagements in the last XX hours.
Social category influence stocks finance currencies cryptocurrencies countries exchanges
Social topic influence $sgmo #2, $4503t #1, $bmrn #5, $xbi #11, $tsha #1, $azn, $pfe #270, $ntla #9, $vtyx, $prax
Top accounts mentioned or mentioned by @zinselmeyerb @rnaianalyst @sangamotx @yusufhameed @shortsellerst @mitchellreed09 @geneinvesting @francaole @auditor112017 @mchilberg @gamalielbaer @biotech2050 @soerenberlin @chromamedicine @davidrliu @bradloncar @sharkbiotech @revshark @biohazard3737 @adamfeuerstein
Top assets mentioned BioMarin Pharmaceutical, Inc. (BMRN) Bitcoin Incognito (XBI) AstraZeneca PLC (AZN) Pfizer, Inc. (PFE) Intellia Therapeutics, Inc (NTLA) Praxis Precision Medicines, Inc. Common Stock (PRAX) CRISPR Therapeutics AG (CRSP) Vertex Protocol (VRTX) Novartis AG (NVS) Synthetify (SNY) AbbVie Inc (ABBV) Arrowhead Research Corporation (ARWR) BridgeBio Pharma, Inc. Common Stock (BBIO) CG Oncology, Inc. Common stock (CGON) Nuvalent, Inc. Class A Common Stock (NUVL) Supernus Pharmaceuticals, Inc. (SUPN) Teva Pharmaceutical Industries Limited American Depositary Shares (TEVA) Dyne Therapeutics, Inc. Common Stock (DYN) Amicus Therapeutics, Inc (FOLD) uniQure N.V. (QURE) Metsera, Inc. Common Stock (MTSR) Novo-Nordisk (NVO) BEAM (BEAM)
Top posts by engagements in the last XX hours
"@Soeren_Berlin now thats funny . MGH Boston and #Astellas signed partnership recently re $SGMO"
X Link @BiotechAnalysst 2025-09-15T13:59Z 4351 followers, 3022 engagements
"@Franca_ole @mikiass0 $BMRN Roctavian summary: -you can #NOT drink alcohol for more that a year -you have to go to a #liver #tox check up ONCE a #week -you #still can #bleed like shit (some XX% (52%) reduction only)"
X Link @BiotechAnalysst 2025-10-28T07:56Z 4349 followers, XXX engagements
"$XBI M&A $BMRN strong enthusiasm + interest in BD activity BD very high priority currently in pursuit of a #number of #deals - ranging from #early-stage to #late-stage/phase3 +even #commercial assets. genetic medicines and rare diseases fit into $BMRN's wheelhouse"
X Link @BiotechAnalysst 2025-10-28T11:36Z 4348 followers, 1349 engagements
"@JaxSmith48060 $AZN took over the full gene therapy assets from $PFE X years ago or so"
X Link @BiotechAnalysst 2025-10-31T13:28Z 4349 followers, XXX engagements
"Funny. X years ago $nvs dumped $sgmo cns program for not having a Propper delivery Option. X years later $sgmo partnered stac-bbb capsid for Alzheimer with Roche. And novartis hiring for capsid Development. Sounds Pretty stupid novartis"
X Link @BiotechAnalysst 2025-10-22T20:08Z 4350 followers, 4685 engagements
"WF think the $VTYX update improves the chances $SNY could do a #deal for VTX3232 and serves as a clearing event ahead of VTX2735's Ph2 data in recurrent pericarditis (deep dive). Shares are up post mkt and should run into the data expected later in 4Q PT $11"
X Link @BiotechAnalysst 2025-10-23T13:24Z 4350 followers, 5929 engagements
"PPR $VTYX VTX3232 Showed Profound hsCRP Reductions w/ Clean Safety PT $21"
X Link @BiotechAnalysst 2025-10-23T13:27Z 4350 followers, XXX engagements
"$XBI Biotech Has a Heartbeat: XX Stocks to Own Through YE25 Sector Driven by . validating clinical data unprecedented innovation and increasing M&A activity $ABBV $ARGX $ARWR $BBIO $CGON $CNTA $COGT $CRSP $DYN $GPCR $KRRO $NUVL $PRAX $SLDB $SUPN $TEVA $URGN"
X Link @BiotechAnalysst 2025-10-24T13:54Z 4350 followers, 1151 engagements
"Astellas also interested in #neuropathic #painting re $SGMO trial speedup to XX weeks vs XX weeks"
X Link @BiotechAnalysst 2025-10-29T07:17Z 4350 followers, 3217 engagements
"Astellas and Takeda both reporting tomorrow . premarket USA re $SGMO BO"
X Link @BiotechAnalysst 2025-10-29T07:37Z 4350 followers, 4035 engagements
"I added XXX Million $sgmo shares today π€"
X Link @BiotechAnalysst 2025-10-29T14:58Z 4349 followers, 6784 engagements
"$SGMO i excuse a delayed PR for XX weeks PAIN Trial news if they waited for the nasdaq letter . btw #Astellas reports premarket USA"
X Link @BiotechAnalysst 2025-10-29T20:39Z 4350 followers, 3869 engagements
"@ZinselmeyerB @UnionSteel2017 @SangamoTx $azn Reports nov X am. π"
X Link @BiotechAnalysst 2025-10-30T20:23Z 4349 followers, XXX engagements
"$NTLA - first they blamed the #patients for the toxic crispr patform - now they blame Adam #Feuerstein for toxic crispr platform -next they will blame #Sangamo for Crispr companies going chapter XX and i cant wait for that to happen π"
X Link @BiotechAnalysst 2025-10-31T08:22Z 4350 followers, 2703 engagements
"if its $AZN i will be shocked i hadnt them on the radar closer and will cease all research activities from my site. π€ re $SGMO buyout"
X Link @BiotechAnalysst 2025-10-31T10:08Z 4350 followers, 3083 engagements
"this is the last update we had on $SGMO + $AZN in ALS " Selective Repression of #C9ORF72 Repeat Expansion-Containing Sense and Antisense Transcripts in an #ALS " re NOV X 8:30 am"
X Link @BiotechAnalysst 2025-10-31T10:14Z 4350 followers, 3219 engagements
"$XBI Theyre designing clinical trials they can use to gain FDA approvals with a gene-editing platform that can be tweaked for patients with different genetic mutations. Its a fundamental shift in how the agency approaches genetic therapies. $SGMO π"
X Link @BiotechAnalysst 2025-10-31T14:23Z 4350 followers, 1834 engagements
"Cantor Takeaways From #Fabry KOL Call "A potential gene therapy ( $SGMO) that gets approved with good efficacy and low side effects could lead the market (patients don't like frequent ERT dosing)." doesnt like $FOLD galafold for severe patience"
X Link @BiotechAnalysst 2025-08-22T15:36Z 4349 followers, 3404 engagements
"$SGMO @ Conference in Fabruary 2026 #AI IN #BIOPHARMA: UNLOCKING POTENTIAL #Astellas says Within #gene #therapy AI is being used to optimize plasmid DNA sequences and drive #capsid #evolution in #collaboration with external partners"
X Link @BiotechAnalysst 2025-10-16T14:01Z 4350 followers, 4512 engagements
"#Astellas returns right to $TSHA #RETT Syndrome programe . (intrathecally delivered AAV9) re $SGMO STAC-BBB #RETT"
X Link @BiotechAnalysst 2025-10-17T05:58Z 4350 followers, 7806 engagements
"$TSHA - Astellas + $SGMO RETT Wedbush: STAC-BBB Neuro Capsids"
X Link @BiotechAnalysst 2025-10-17T06:10Z 4349 followers, 11.7K engagements
"$SGMO #Rett #Syndrome also mentioned as Target for #MINT re #Astellas dropping $TSHA"
X Link @BiotechAnalysst 2025-10-17T07:53Z 4350 followers, 7979 engagements
"#Astellas not buying $TSHA re but $SGMO"
X Link @BiotechAnalysst 2025-10-17T09:58Z 4350 followers, 4063 engagements
"Cantor says $TSHA roughly 1/3 $QURE market cap despite both: latestage derisking data regulatory support both sizable rare disease markets $QURE 5-6K patients vs 10K patients for $TSHA i say same goes for $SGMO but with 25K+ Fabry patients $SGMO marketcap 190M or 1/17 $QURE"
X Link @BiotechAnalysst 2025-10-18T11:55Z 4349 followers, 3616 engagements
"from raymond James $TSHA initiation tonight regarding $NGNE re #Astellas looking for $SGMO for RETT imo"
X Link @BiotechAnalysst 2025-10-21T15:12Z 4350 followers, 2656 engagements
"@appalachiangabe @Maasta1234 @Franca_ole Astellas will buy $SGMO imo . owing the Hemophilia Assett . BIG PROBLEM for TAKEDA s Hemophilia franchise. Takeda should take the Hemophilia prog from SGAMO before astellas or when astellas buys Sangamo just imho"
X Link @BiotechAnalysst 2025-10-22T15:11Z 4350 followers, 5776 engagements
"$BMRN plans to fully divest from Roctavian and explore out-licensing opportunities (LOL) $BMRN Roctavian sales: Q1 $11M Q2 $9M Q3 $3M patients see that this "drug" is worst ever useless POS see below: no alcohol liver tox monitoring still bleed. now $BMRN going FULL ERTπ€¦π»"
X Link @BiotechAnalysst 2025-10-28T07:50Z 4349 followers, 1433 engagements
"$BMRN Mgmnt mentioned $2BN in cash and capacity to execute on $X to $5BN in BD. Mgmnt called out many #rare #disease focused biotechs who are #undercapitalized and #underresourced that represent an #attractive opportunities for BMRN re $XBI M&A"
X Link @BiotechAnalysst 2025-10-28T11:41Z 4349 followers, 3731 engagements
"$BMRN up X% on "we will buy us a new pipeline with $XBI biotech M&A""
X Link @BiotechAnalysst 2025-10-28T13:35Z 4349 followers, XXX engagements
"@RNAiAnalyst $WVE how do you measure . (GLP-1 widely used now) what % do we want to see"
X Link @BiotechAnalysst 2025-10-28T16:35Z 4349 followers, 2637 engagements
"$MTSR $PFE $NVO What is the difference between the deals"
X Link @BiotechAnalysst 2025-10-30T11:42Z 4349 followers, 1991 engagements
"updated #Astellas site now names #Gene #Regulation as primary focus "New technologies to #replace or #regulate #genes safely have advanced rapidly and are #now a #reality." re $SGMO #MINT integrase Platform re $SGMO ZFR platform"
X Link @BiotechAnalysst 2025-10-08T13:25Z 4349 followers, 9476 engagements
"$BMRN WellsFargo says: "We have cut our numbers to assume #aggressive #erosion of #Voxzogo - We now assume XX% share loss to #competition within X years starting 2026 in the US and 2027 in EU." only aggressive $XBI M&A can help $BMRN from here what is Elliott doing all day"
X Link @BiotechAnalysst 2025-10-28T07:59Z 4349 followers, 2180 engagements
"$NTLA thats why its not trading single digits . YET"
X Link @BiotechAnalysst 2025-10-28T10:23Z 4349 followers, 3453 engagements
"@somerussell @Corona_N_Lyme $VRTX $BMRN Astellas Takeda"
X Link @BiotechAnalysst 2025-10-28T13:38Z 4349 followers, XXX engagements
"RaymondJames met $BMRN on appetite for M&A specifically companies with late-stage or approved treatments for rare genetically defined disorders priced $1.5B Based on commentary they performed a screen of the Biomedtracker drug database: $MAZE $ETON $STOK $AVXL $PRAX $RZLT $APLT"
X Link @BiotechAnalysst 2025-09-17T11:23Z 4349 followers, 14.7K engagements
"$XBI FDA signals regulatory flexibility for #gene #editing going to be extremely flexible + work very fast publish a paper in #early #November outlining the FDA new regulatory approach with the expectation for investment to flow into the space once published $SGMO $BEAM $PRME"
X Link @BiotechAnalysst 2025-11-01T09:35Z 4349 followers, 3998 engagements
"2 sider report on $VRTX in @aktionaer talking about Pipeline #setbacks in Journavx for #pain not mentioning $SGMO yet . but Der Aktionr has been a big fan of Sangamo in recent years . looking forward to more $SGMO covering from @doepke_michel in the near future "
X Link @BiotechAnalysst 2025-11-01T11:10Z 4349 followers, 3370 engagements
"@Soeren_Berlin $SGMO manipulation going next stage"
X Link @BiotechAnalysst 2025-11-01T18:28Z 4349 followers, 1447 engagements